SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-033175
Filing Date
2019-05-31
Accepted
2019-05-31 17:17:18
Documents
8
Period of Report
2019-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-10747_38k.htm 8-K 31880
2 EX-1.1 a19-10747_3ex1d1.htm EX-1.1 270083
3 EX-5.1 a19-10747_3ex5d1.htm EX-5.1 18035
4 EX-99.1 a19-10747_3ex99d1.htm EX-99.1 9674
5 EX-99.2 a19-10747_3ex99d2.htm EX-99.2 10627
6 GRAPHIC g107473mmi001.jpg GRAPHIC 2730
7 GRAPHIC g107473kii001.jpg GRAPHIC 3234
8 GRAPHIC g107473moi001.jpg GRAPHIC 2730
  Complete submission text file 0001104659-19-033175.txt   353900
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 19871425
SIC: 2834 Pharmaceutical Preparations